|Bid||68.96 x 0|
|Ask||69.22 x 0|
|Day's Range||70.83 - 70.83|
|52 Week Range||38.51 - 80.95|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DaVita Kidney Care stands with the National Kidney Foundation and its open letter urging hospitals and health systems not to limit care to end stage kidney disease (ESKD) patients with COVID-19 who need life-saving interventions. This advocacy effort is in response to news reports that some state governments and hospital systems are examining crisis-management policies that would restrict access to critical COVID-19 treatments, such as ventilators, for certain patient groups, one of which is patients with ESKD.
“There’s not a one-size-fits-all solution,” Dr. Jeffrey Giullian, chief medical officer, told Denver Business Journal.
The number of cases of the coronavirus that causes COVID-19 topped 1 million on Thursday as U.S. jobless claims soared to record levels, offering a grim look at how the illness is hurting businesses, individuals and the economy.
DaVita Inc. said Thursday that it plans to hire at least 15,000 new employees this year, from jobs ranging from care giving to corporate support. The kidney care services company said previous health care experience is not required for many of the new roles. The open positions include nurses, social workers, registered dieticians, biomedical technicians, managment roles and corporate roles from IT, insurance, people services, executive assistants and revenue operations. The stock, which is still inactive in premarket trading, has lost 3.5% over the past three months, while the S&P 500 has shed 24.2%.
DaVita Kidney Care recently announced its plans to hire at least 15,000 new employees, known as teammates, throughout 2020. Available positions range from care giving roles in centers across the U.S. to corporate support roles. For many of these open positions, previous experience in health care is not required.
The two companies and other organizations are committed to providing dialysis while limiting exposure.
Fresenius Medical Care (FMC) on Wednesday said it was working with other dialysis providers to provide care in isolation for people with kidney problems in the United States who are or may be infected with coronavirus. FMC, the world's largest kidney dialysis provider, said it was collaborating with DaVita Inc., U.S. Renal Care, American Renal Associates, Satellite Healthcare and others on making a national contingency plan to ensure patients who need dialysis can continue to receive care by creating isolation capacity that other providers can use. "The companies are focused on ensuring there are enough nurses, social workers, dietitians, care technicians and available space to treat all dialysis patients, including those who are or may be infected with COVID-19, in a way that does not unnecessarily expose the hundreds of thousands of other patients who entrust them with their care," FMC said.
Fresenius Medical Care North America (FMCNA) and DaVita Inc. (DVA) today announced a collaboration in response to Novel Coronavirus (COVID-19), which aims to support the broader kidney care community by offering isolation capacity for dialysis patients who are or may be COVID-19 positive.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Meanwhile, Gov. Polis said he's considered a shelter-in-place order that would restrict business even further, but he doesn't see the need yet for that kind of harrowing economic impact.
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Some of the largest health care stocks in the world include Johnson & Johnson (JNJ) and Pfizer, Inc. (PFE).
DaVita Hospital Services Group today announced that Dr. David Mahoney has assumed the role of chief medical officer (CMO). Dr. Mahoney succeeds Dr. Jeff Giullian, who now serves as chief medical officer for DaVita Kidney Care.
DaVita Kidney Care achieved another industry first by incorporating a secure telehealth platform, DaVita Care Connect™, into its home dialysis program. DaVita Care Connect™ is one of many connective technologies in its suite of services designed to improve outcomes and the care experience for patients choosing to treat at home.
Fresenius Medical Care (FMC) , the world's largest kidney dialysis provider, is confident the U.S. government will soften initial targets for treating patients with kidney disease at home rather than in dedicated centres. Chief Executive Rice Powell told Reuters a goal laid out by the U.S. Department of Health and Human Services (HHS) last July for 80% of new patients to undergo dialysis at home or receive organ transplants by 2025 was under review amid industry criticism. While Fresenius is developing less bulky and easier-to-use dialysis equipment and smartphone apps for home treatment, Powell said dialysis companies risked financial penalties if they kept patients who were deemed unsuitable for home treatment in dialysis centres under the new goals.
DaVita Kidney Care recently announced Kenny Gardner as its new chief people officer (CPO). Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.
The company continues to focus on state policy, but will not pursue its own ballot initiative in California.
Today we're going to take a look at the well-established DaVita Inc. (NYSE:DVA). The company's stock saw a significant...